Tori Rodriguez, MA, LPC, AHC

Louise Pilote, MD, Annabelle Santos Volgman, MD, and Salvatore Savona, MD, discuss sex-based health disparities in atrial fibrillation.

Matthew L. Springer, PhD, Sandhya Venugopal, MD, and Kinjan Parikh, MD, discuss the effect of e-cigarettes on cardiovascular health.

As the opioid epidemic worsens, rates of drug use-related infective endocarditis and associated procedures have grown substantially.

Findings published in 2020 suggest that irregular sleep schedules may increase CVD risk independent of sleep quality or duration.

Sameed Khatana MD, and Barrak Alahmad, MD, discuss the impact of climate change on patients’ risk for cardiovascular disease.

Gregory M Marcus, MD, MAS, and Jeffrey J. Hsu, MD, PhD, discuss the effect of caffeine and energy supplements on risk for cardiovascular events.

Viola Vaccarino, MD, PhD, Yuan Lu, ScD, and Ersilia M. DeFilippis, MD, discuss increasing rates of myocardial infarction among young women.

Joseph M Truglio, MD, Ali N. Zaidi, MD, Monica V. Dragoman, MD, and Linda Cassar, DNP, RNC-OB, CNE, discuss the effect of the overturning of Roe v Wade on patients with CVD.

A look into increased cardiovascular risk in patients who are transgender and suggestions for how to improve their health care.

Tamara Horwich, MD, Eugenia Gianos, MD, and Kenneth Fleisher, DDS, reflect on the link between cardiovascular disease and oral health.

Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.

Radmila Lyubarova, MD, and Michael G. Nanna, MD, discuss the lack of awareness regarding risk for ASCVD in women and disparities in treatment that they face.

The understudied relationship between muscle mass and nonalcoholic fatty liver disease is assessed, including expert opinions the topic.

In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.

Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.

To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.

A significant number of cases of post-COVID-19 myocarditis have been reported.

Cardiologists around the world report experiencing harassment and discrimination in the workplace.

Higher rates of smoking, lower rates of lung cancer screening, and more diagnoses of asthma and COPD have been seen in transgender vs cisgender individuals.

With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.

About 90% of those with familial hypercholesterolemia have not been diagnosed or treated for it, leaving them more vulnerable for COVID-19 infection and its complications.

Lipid-lowering therapies are key to the prevention of cardiovascular (CV) events and CV-related mortality.

Mechanistic and outcomes studies are warranted to elucidate the lipid paradox and CVD risk in rheumatoid arthritis (RA).

Changes to restrictions for telemedicine may have important implications for the management of adult and pediatric diabetes during the COVID-19 pandemic.

Familial hypercholesterolemia is one of the most clinically relevant monogenic disorders contributing to the development of atherosclerotic cardiovascular disease.

The clinical approach to management of Cushing disease is often complex and education on a clear approach is paramount.

The benefits of treating overt hypothyroidism in women who are pregnant or planning pregnancy are clear, but there is less clarity regarding the maternofetal and neonatal effects of subclinical hypothyroidism.

Emerging evidence suggests that the extrapulmonary effects of pulmonary arterial hypertension may manifest in the form of vascular dysfunction in systemic circulation, metabolic/endocrine dysfunction, and skeletal and respiratory muscle dysfunction.

Evidence suggests that even after optimal treatment with surgical and pharmacologic interventions, health-related quality of life remains impaired in patients with pituitary disease.

Rates of marijuana use are especially high among men and women of reproductive age. How should physicians advise patients who are trying to conceive about marijuana?